a Sanofi Genzyme takes on world's top-selling drugs with new approval

... also happen to be for that same disease: give it a lower price. Cambridge-based Sanofi Genzyme (NYSE: SNY) and Tarrytown, N.Y.-based Regeneron (NYSE: REGN) will market their new drug, which has the generic name of...
http://ift.tt/2rctXCV